Nuo Therapeutics, Inc. (AURX) has 13 open-market insider trades by 4 insiders since 2017. The most active filer is Charles E. Sheedy, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Charles E. Sheedy | 10% Owner | — | 8 | $2.8M | 2025-07-30 |
| Boyalife Investment Fund I, Inc. | 10% Owner | — | 1 | $693K | 2017-09-11 |
| Scott M. Pittman | Dir10% Owner | — | 1 | $607K | 2026-06-30 |
| David Emerson Jorden | CEOCFO | — | 3 | $523K | 2026-08-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Emerson Jorden | CEO & CFO | Sell | $300K | 2025-11-28 |
| Charles E. Sheedy | 10% Owner | Buy | $400K | 2025-07-30 |
| Charles E. Sheedy | 10% Owner | Buy | $94K | 2024-09-18 |
| Charles E. Sheedy | 10% Owner | Buy | $75K | 2024-05-20 |
| Charles E. Sheedy | 10% Owner | Buy | $75K | 2023-12-19 |
| Charles E. Sheedy | 10% Owner | Buy | $125K |
Companies that share insiders with AURX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-08-01 |
| David Emerson Jorden | CEO/CFO | Sell | $169K | 2022-11-09 |
| Charles E. Sheedy | 10% Owner | Buy | $805K | 2022-04-29 |
| Charles E. Sheedy | 10% Owner | Buy | $70K | 2020-10-05 |
| Boyalife Investment Fund I, Inc. | 10% Owner | Buy | $693K | 2017-09-11 |
| David Emerson Jorden | CEO & CFO | Buy | $54K | 2017-08-10 |
| Scott M. Pittman | Director & 10% Owner | Buy | $607K | 2017-08-10 |
| Charles E. Sheedy | 10% Owner | Buy | $1.1M | 2017-08-10 |